Raydiant Oximetry
Latest round
- Series A
Last raised
- May 2024
Total raised
- $18M
Investors
- 15
About Raydiant Oximetry
Founded in 2015, Raydiant Oximetry, Inc. operates out of San Ramon, US, and specializes in fetal health monitoring. Neil Ray serves as both the founder and CEO, guiding the company through its current developments. The firm has successfully completed 13 deals to date, with its most recent deal occurring on May 28, 2024.Raydiant Oximetry specializes in advancing fetal health monitoring through its core product, Lumerah™, a noninvasive sensor technology designed to directly measure fetal oxygen levels during childbirth. This innovative fetal pulse oximeter aims to significantly reduce the mortality and morbidity rates among mothers and infants, addressing critical issues related to current electronic fetal monitoring practices. The technology has been shown to improve the sensitivity and specificity in detecting fetal distress, which is vital for obstetrical providers who require reliable tools for evaluating fetal oxygenation. Lumerah™ is currently in the preclinical trial phase and has received 'Breakthrough Device' status from the FDA to expedite its market approval.Raydiant Oximetry's revenue model is structured around B2B transactions with healthcare providers, including hospitals and obstetrical clinics that require advanced fetal monitoring solutions. The business transactions typically involve direct sales agreements or partnerships with healthcare entities, allowing these providers to integrate Lumerah™ into their existing labor and delivery protocols. The organization has also secured grants from multiple sources, such as the Bill & Melinda Gates Foundation and the government of Ireland, which further supports its developmental efforts.In May 2024, Raydiant Oximetry, Inc. The strategy includes accelerating the deployment of Lumerah™ in clinical settings as it moves closer to market approval, with expectations to enhance maternal and neonatal care significantly.
Who invested in Raydiant Oximetry
15 investors across 4 rounds
See all investors in Raydiant Oximetry
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Raydiant Oximetry
Who invested in Raydiant Oximetry?
Raydiant Oximetry has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Raydiant Oximetry raised?
Raydiant Oximetry has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Raydiant Oximetry last raise money?
Raydiant Oximetry's most recent round on record is a Series A, in May 2024.
What does Raydiant Oximetry do?
Founded in 2015, Raydiant Oximetry, Inc.
Where is Raydiant Oximetry headquartered?
Raydiant Oximetry is headquartered in San Ramon, US.
Which VCs invest in companies like Raydiant Oximetry?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Raydiant Oximetry's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Raydiant Oximetry? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.